MarketPeel
Insider Trading Intelligence
Pricing
…
CB

Cheryl R. Blanchard

ANIK
PRESIDENT, CEO, DIRECTOR · ANIKA THERAPEUTICS, INC. · CIK 0001326530
FILING MIX · LIFETIME57%/43%
BUYS
39
SELLS
29
TOTAL VALUE
$2.80M
COMPANIES
4
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
109,569
AVG SELL PX
$20.53
TRADE KIND
SHOWING 68 / 68
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Cheryl R. Blanchard, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+10.48%+6.15%+4.33%+4.33%—
14d2+100.00%+1.06%+8.10%-7.04%-7.04%—
30d2+0.00%-6.45%+5.05%-11.50%-11.50%—
60d2+0.00%-16.93%-4.70%-12.23%-12.23%—
90d2+0.00%-14.23%-4.14%-10.09%-10.09%—
180d2+0.00%-9.30%-4.60%-4.70%-4.70%—
1y2+100.00%+2.03%-6.64%+8.67%+8.67%—
2y2+100.00%+0.82%+25.57%-24.75%-24.75%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIK · 25,132 shares · as of Mar 15, 2026
067,723135,446203,169270,892202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 39 buys / 29 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XLO
XILIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Apr 15, 2026Apr 16, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
25,131——270,892Mar 15, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
12,104$14.20$171.9K258,788Mar 15, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
25,131——25,132Mar 15, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
24,519——235,969Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
24,519——49,040Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
14,728$14.20$209.1K245,761Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,520——260,489Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
5,871$14.96$87.8K211,450Mar 9, 2026Mar 11, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
20,001——0Mar 9, 2026Mar 11, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
20,001——217,321Mar 9, 2026Mar 11, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
25,132——50,263Mar 17, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
25,132——209,472Mar 17, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
12,152$15.91$193.3K197,320Mar 17, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
71,403——71,403Mar 14, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
73,559——73,559Mar 14, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
30,060——0Mar 11, 2025Mar 13, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
12,675$16.79$212.8K184,340Mar 11, 2025Mar 13, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
30,060——197,015Mar 11, 2025Mar 13, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
20,002——172,826Mar 10, 2025Mar 11, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
20,002——20,001Mar 10, 2025Mar 11, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
5,871$16.62$97.6K166,955Mar 10, 2025Mar 11, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,395——75,395Mar 15, 2024Mar 19, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
182,699——182,699Mar 15, 2024Mar 19, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
30,059——166,228Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
6,973$25.42$177.3K122,641Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
14,534$25.79$374.8K151,694Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
20,001——142,642Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
14,420——129,614Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
14,420——0Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
20,001——40,003Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
6,473$25.42$164.5K136,169Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
30,059——30,060Mar 11, 2024Mar 12, 2024 ↗View →
DARE
DARE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 21, 2023Jun 21, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
24,575——0Apr 26, 2023Apr 28, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
10,900$26.34$287.1K114,255Apr 26, 2023Apr 28, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
24,575——125,155Apr 26, 2023Apr 28, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
13,211$26.10$344.8K100,580Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
30,060——60,119Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
30,060——113,791Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
14,419——87,963Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
130,998——130,998Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,004——60,004Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
4,232$26.91$113.9K83,731Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
14,419——14,420Mar 9, 2023Mar 10, 2023 ↗View →
DARE
DARE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
38,000——38,000Jun 23, 2022Jun 23, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
24,576——72,826Apr 26, 2022Apr 28, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
24,576——24,575Apr 26, 2022Apr 28, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
4,287$25.36$108.7K56,179Mar 11, 2022Mar 14, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
3,813$25.81$98.4K59,992Mar 11, 2022Mar 14, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
208,821——208,821Mar 11, 2022Mar 15, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,179——90,179Mar 11, 2022Mar 15, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
14,420——51,892Mar 9, 2022Mar 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
14,420——28,839Mar 9, 2022Mar 11, 2022 ↗View →
DARE
DARE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 24, 2021Jun 24, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
2,994——101,644Jun 15, 2021Jun 17, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
2,994$33.40$100.0K37,472Jun 15, 2021Jun 17, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
24,575——34,478Apr 26, 2021Apr 28, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
24,575——49,151Apr 26, 2021Apr 28, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
108,398——108,398Mar 9, 2021Mar 11, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,259——43,259Mar 9, 2021Mar 11, 2021 ↗View →
DARE
DARE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
22,500——22,500Jun 25, 2020Jun 26, 2020 ↗View →
STIM
NEURONETICS, INC.
PURCHASEGRANT
Stock grant
30,000——34,437May 26, 2020May 28, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
104,638——104,638Apr 26, 2020Apr 28, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
President, CEO, Director
4,231——11,697Apr 26, 2020Apr 28, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
73,726——73,726Apr 26, 2020Apr 28, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
President, CEO, Director
1,794$33.40$59.9K9,903Apr 26, 2020Apr 28, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,231——4,231Feb 25, 2020Feb 27, 2020 ↗View →
Other insiders · ANIK
Loading peer insiders…
About this filer
CIK 0001326530
ROLE
President, CEO, Director
PRIMARY
ANIK
COMPANIES
4
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001326530DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback